
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1044 | 948 | 1044 | 1115 | 1366 | 1783 |
Fund Return | 4.39% | -5.18% | 4.39% | 3.7% | 6.43% | 5.96% |
Place in category | 1592 | 1866 | 1592 | 576 | 559 | 454 |
% in Category | 79 | 90 | 79 | 32 | 36 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Private Banking VermogensportfolPI4 | 149.75M | -1.41 | 1.99 | 2.44 | ||
Vermogensportfolio Nachh 70 AK 1 | 1.91B | -1.58 | 1.28 | 1.73 | ||
Private Banking Vermogensportfolio | 53.94M | -0.93 | 1.57 | 1.76 | ||
Private Banking VermogensportfolPI3 | 66.11M | -1.01 | 1.27 | 1.45 | ||
Amundi Substanzwerte | 70.5M | 9.75 | 1.71 | 2.63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Strategic European EquiD | 3.7B | 17.60 | 10.31 | 9.12 | ||
Wellington Strategic European EquNE | 3.7B | 18.40 | 11.15 | 9.95 | ||
Wellington Strategic European EquiS | 3.7B | 18.57 | 11.31 | 10.10 | ||
AriDeka CF | 2.68B | 7.47 | 2.81 | 5.49 | ||
Industria P EUR | 1.4B | 4.01 | 4.66 | 5.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.30 | 425.7 | -2.34% | |
ASML Holding | NL0010273215 | 4.26 | 605.40 | +2.61% | |
Roche Holding Participation | CH0012032048 | 3.92 | 255.40 | +1.47% | |
Schneider Electric | FR0000121972 | 3.24 | 208.70 | +3.06% | |
Allianz | DE0008404005 | 3.02 | 343.00 | +1.57% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review